Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
about
The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapyExploring leptin antagonism in ophthalmic cell modelsEffects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells.Review of application of mass spectrometry for analyses of anterior eye proteome.Evaluating the safety of intracameral bevacizumab application using oxidative stress and apoptotic parameters in corneal tissue.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.
P2860
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
@en
type
label
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
@en
prefLabel
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
@en
P2093
P2860
P1433
P1476
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
@en
P2093
Kakarla V Chalam
Monali Sakhalkar
Raluca Rusovici
P2860
P304
P577
2011-12-20T00:00:00Z